Free Trial

H. B. Fuller (FUL) Competitors

H. B. Fuller logo
$56.16 +1.59 (+2.91%)
Closing price 03:59 PM Eastern
Extended Trading
$55.25 -0.91 (-1.62%)
As of 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FUL vs. ALB, CE, NEU, BCPC, SXT, ASH, IOSP, KWR, MTX, and SCL

Should you be buying H. B. Fuller stock or one of its competitors? The main competitors of H. B. Fuller include Albemarle (ALB), Celanese (CE), NewMarket (NEU), Balchem (BCPC), Sensient Technologies (SXT), Ashland (ASH), Innospec (IOSP), Quaker Chemical (KWR), Minerals Technologies (MTX), and Stepan (SCL). These companies are all part of the "specialty chemicals" industry.

H. B. Fuller vs. Its Competitors

Albemarle (NYSE:ALB) and H. B. Fuller (NYSE:FUL) are both mid-cap basic materials companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, profitability, community ranking, valuation, dividends and risk.

Albemarle has a beta of 1.61, suggesting that its share price is 61% more volatile than the S&P 500. Comparatively, H. B. Fuller has a beta of 1.12, suggesting that its share price is 12% more volatile than the S&P 500.

In the previous week, Albemarle had 6 more articles in the media than H. B. Fuller. MarketBeat recorded 10 mentions for Albemarle and 4 mentions for H. B. Fuller. Albemarle's average media sentiment score of 0.86 beat H. B. Fuller's score of 0.27 indicating that Albemarle is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Albemarle
6 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
H. B. Fuller
0 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

H. B. Fuller has a net margin of 3.17% compared to Albemarle's net margin of -22.39%. H. B. Fuller's return on equity of 11.57% beat Albemarle's return on equity.

Company Net Margins Return on Equity Return on Assets
Albemarle-22.39% -1.92% -0.92%
H. B. Fuller 3.17%11.57%4.23%

92.9% of Albemarle shares are owned by institutional investors. Comparatively, 95.9% of H. B. Fuller shares are owned by institutional investors. 0.3% of Albemarle shares are owned by company insiders. Comparatively, 2.0% of H. B. Fuller shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

H. B. Fuller has lower revenue, but higher earnings than Albemarle. Albemarle is trading at a lower price-to-earnings ratio than H. B. Fuller, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Albemarle$5.38B1.27-$1.18B-$11.12-5.21
H. B. Fuller$3.57B0.85$130.26M$2.0028.08

Albemarle pays an annual dividend of $1.62 per share and has a dividend yield of 2.8%. H. B. Fuller pays an annual dividend of $0.94 per share and has a dividend yield of 1.7%. Albemarle pays out -14.6% of its earnings in the form of a dividend. H. B. Fuller pays out 47.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Albemarle has raised its dividend for 30 consecutive years and H. B. Fuller has raised its dividend for 57 consecutive years. Albemarle is clearly the better dividend stock, given its higher yield and lower payout ratio.

Albemarle presently has a consensus price target of $91.62, suggesting a potential upside of 58.24%. H. B. Fuller has a consensus price target of $62.50, suggesting a potential upside of 11.29%. Given Albemarle's higher probable upside, equities research analysts plainly believe Albemarle is more favorable than H. B. Fuller.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Albemarle
2 Sell rating(s)
14 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.14
H. B. Fuller
1 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.43

Albemarle received 460 more outperform votes than H. B. Fuller when rated by MarketBeat users. Likewise, 61.78% of users gave Albemarle an outperform vote while only 55.48% of users gave H. B. Fuller an outperform vote.

CompanyUnderperformOutperform
AlbemarleOutperform Votes
779
61.78%
Underperform Votes
482
38.22%
H. B. FullerOutperform Votes
319
55.48%
Underperform Votes
256
44.52%

Summary

Albemarle and H. B. Fuller tied by winning 11 of the 22 factors compared between the two stocks.

Get H. B. Fuller News Delivered to You Automatically

Sign up to receive the latest news and ratings for FUL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FUL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FUL vs. The Competition

MetricH. B. FullerCHEM IndustryMaterials SectorNYSE Exchange
Market Cap$3.04B$15.56B$3.19B$19.76B
Dividend Yield1.72%2.02%5.17%3.81%
P/E Ratio28.0817.2574.9927.18
Price / Sales0.853.1025,591,212,775,284,500.0032.59
Price / Cash7.6112.5323.8317.51
Price / Book1.683.065.844.45
Net Income$130.26M$421.06M$150.65M$986.05M
7 Day Performance3.11%-0.98%0.84%-0.19%
1 Month Performance3.58%2.18%8.18%3.72%
1 Year Performance-28.01%6.09%25.74%10.60%

H. B. Fuller Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FUL
H. B. Fuller
4.4019 of 5 stars
$56.16
+2.9%
$62.50
+11.3%
-30.1%$3.04B$3.57B28.087,500Upcoming Earnings
ALB
Albemarle
4.4238 of 5 stars
$60.94
+0.4%
$91.62
+50.4%
-40.1%$7.17B$5.09B-5.447,400
CE
Celanese
4.1746 of 5 stars
$56.21
+2.9%
$63.11
+12.3%
-60.9%$6.15B$10.06B-4.0413,300Positive News
NEU
NewMarket
2.9956 of 5 stars
$638.34
-1.2%
N/A+24.4%$6.02B$2.79B13.242,060Positive News
High Trading Volume
BCPC
Balchem
4.4181 of 5 stars
$160.00
-0.9%
$180.00
+12.5%
+2.9%$5.22B$964.54M40.711,340Positive News
SXT
Sensient Technologies
2.8186 of 5 stars
$94.72
0.0%
$94.00
-0.8%
+28.9%$4.02B$1.56B32.224,090Positive News
ASH
Ashland
4.3728 of 5 stars
$50.20
+1.2%
$68.60
+36.6%
-49.7%$2.29B$1.95B-76.063,900
IOSP
Innospec
2.1413 of 5 stars
$84.41
-0.4%
N/A-33.0%$2.11B$1.79B59.442,100
KWR
Quaker Chemical
3.9286 of 5 stars
$116.18
+1.1%
$159.25
+37.1%
-32.8%$2.05B$1.81B17.044,600
MTX
Minerals Technologies
3.9982 of 5 stars
$54.56
+0.8%
$80.00
+46.6%
-36.6%$1.73B$2.08B10.534,070Positive News
SCL
Stepan
3.9847 of 5 stars
$54.99
+1.0%
N/A-34.8%$1.24B$2.22B24.882,450Positive News

Related Companies and Tools


This page (NYSE:FUL) was last updated on 6/23/2025 by MarketBeat.com Staff
From Our Partners